97 related articles for article (PubMed ID: 28802736)
1. Synthesis of PEGylated polyglutamic acid peptide dendrimer and its application in dissolving thrombus.
Zhang SF; Gao C; Lü S; He J; Liu M; Wu C; Liu Y; Zhang X; Liu Z
Colloids Surf B Biointerfaces; 2017 Nov; 159():284-292. PubMed ID: 28802736
[TBL] [Abstract][Full Text] [Related]
2. Multiarm-polyethylene glycol-polyglutamic acid peptide dendrimer: Design, synthesis, and dissolving thrombus.
Zhang SF; Lü S; Gao C; Yang J; Yan X; Li T; Wen N; Huang M; Liu M
J Biomed Mater Res A; 2018 Jun; 106(6):1687-1696. PubMed ID: 29468794
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of mesoporous silica/polyglutamic acid peptide dendrimer with dual targeting and its application in dissolving thrombus.
Huang M; Zhang SF; Lü S; Qi T; Yan J; Gao C; Liu M; Li T; Ji Y
J Biomed Mater Res A; 2019 Aug; 107(8):1824-1831. PubMed ID: 31012233
[TBL] [Abstract][Full Text] [Related]
4. Layer-by-layer self-assembly embedding of nattokinase in chitosan/γ-polyglutamic acid: Preparation, fibrinolytic activity, stability, and in vitro digestion study.
Liu Z; He Y; Zhang H; Ma X
Eur J Pharm Biopharm; 2024 Jun; 199():114281. PubMed ID: 38599299
[TBL] [Abstract][Full Text] [Related]
5. In vitro enzymatic stability of dendritic peptides.
Yang H; Lopina ST
J Biomed Mater Res A; 2006 Feb; 76(2):398-407. PubMed ID: 16270346
[TBL] [Abstract][Full Text] [Related]
6. Construction of polylysine dendrimer nanocomposites carrying nattokinase and their application in thrombolysis.
Wu C; Gao C; Lü S; Xu X; Wen N; Zhang S; Liu M
J Biomed Mater Res A; 2018 Feb; 106(2):440-449. PubMed ID: 28891111
[TBL] [Abstract][Full Text] [Related]
7. A nano polymer conjugate for dual drugs sequential release and combined treatment of colon cancer and thrombotic complications.
Huang M; Ji Y; Yan J; Qi T; Zhang SF; Li T; Lü S; Liu Y; Liu M
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110697. PubMed ID: 32204009
[TBL] [Abstract][Full Text] [Related]
8. Poly-glutamic dendrimer-based conjugates for cancer vaccination - a computational design for targeted delivery of antigens.
Moura LIF; Martinho N; Silva LC; Barata TS; Brocchini S; Florindo HF; Zloh M
J Drug Target; 2017; 25(9-10):873-880. PubMed ID: 28795601
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamic acid-PEG nanocapsules as long circulating carriers for the delivery of docetaxel.
Lollo G; Rivera-Rodriguez GR; Bejaud J; Montier T; Passirani C; Benoit JP; García-Fuentes M; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2014 May; 87(1):47-54. PubMed ID: 24530693
[TBL] [Abstract][Full Text] [Related]
10. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
11. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of triblock ABA type peptide dendrimer based on glutamic acid dimethyl ester and PEG as a potential nano drug delivery agent.
Namazi H; Toomari Y; Abbaspour H
Bioimpacts; 2014; 4(4):175-82. PubMed ID: 25671173
[TBL] [Abstract][Full Text] [Related]
13. A novel dendrimer based on poly (L-glutamic acid) derivatives as an efficient and biocompatible gene delivery vector.
Zeng X; Pan S; Li J; Wang C; Wen Y; Wu H; Wang C; Wu C; Feng M
Nanotechnology; 2011 Sep; 22(37):375102. PubMed ID: 21852739
[TBL] [Abstract][Full Text] [Related]
14. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
15. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers.
Kojima C; Regino C; Umeda Y; Kobayashi H; Kono K
Int J Pharm; 2010 Jan; 383(1-2):293-6. PubMed ID: 19761822
[TBL] [Abstract][Full Text] [Related]
16. The anti-tumor efficiency of poly(L-glutamic acid) dendrimers with polyhedral oligomeric silsesquioxane cores.
Pu Y; Chang S; Yuan H; Wang G; He B; Gu Z
Biomaterials; 2013 May; 34(14):3658-66. PubMed ID: 23433775
[TBL] [Abstract][Full Text] [Related]
17. Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size.
Abellan-Pose R; Teijeiro-Valiño C; Santander-Ortega MJ; Borrajo E; Vidal A; Garcia-Fuentes M; Csaba N; Alonso MJ
Int J Pharm; 2016 Jul; 509(1-2):107-117. PubMed ID: 27210735
[TBL] [Abstract][Full Text] [Related]
18. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.
Kesharwani P; Tekade RK; Jain NK
Biomaterials; 2014 Jul; 35(21):5539-48. PubMed ID: 24731713
[TBL] [Abstract][Full Text] [Related]
19. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
20. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
